Megadose clonazepam dependence: A case report [20]

Journal of Clinical Psychopharmacology

Volumn 27, Issue 5, 2007, Pages 542-543

  Mowla, Arash ^a   Firoozabadi, Ali ^a   Haghighi, Afshin Borhani ^a   Sahraian, Ali ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM;

ADULT; AGITATION; ALCOHOL ABUSE; ANAMNESIS; BORDERLINE STATE; CANNABIS ADDICTION; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MEGADOSE; FEMALE; HUMAN; INSOMNIA; LETTER; MENTAL STRESS; PRIORITY JOURNAL; SIDE EFFECT;

ADULT; ANTICONVULSANTS; BORDERLINE PERSONALITY DISORDER; CARBAMAZEPINE; CLONAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; FEMALE; GABA MODULATORS; HUMANS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 34548689611     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181506e4e     Document Type: Letter

References (10)

1. Skodol AE, Gunderson JG, Pfohl B, et al. The borderline diagnosis. I: psychopathology, comorbidity, and personality structure. Biol Psychiatry. 2002;51:936-950.
2. Browne TR. Clonazepam. N Engl J Med. 1978; 299(15):812-816.
3. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview of Axis-I DSM-IV Disorders - Patient Edition (SCID-I/P, version 2.0). New York: Biometric Research Department, New York State Psychiatric Institute; 1994.
4. Schweizer E, Rickels K, Case WG, et al. Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome. Arch Gen Psychiatry. 1991;48(5):448-452.
5. Rickels K, DeMartinis N, Rynn M, et al. Pharmacologic strategies for discontinuing benzodiazepine treatment. J Clin Psychopharmacol. 1999;19(6 suppl 2):12S-16S.
6. Dulit R, Fyer M, Haas G, et al. Substance use in borderline personality disorder. Am J Psychiatry. 1990;147:1002-1007.
7. Cowdry RW, Gardner DL. Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry. 1988;45(2): 111-119.
8. Martinez-Cano H, Vela-Bueno A, De Iceta M, et al. Benzodiazepine types in high dose versus therapeutic dose dependence. Addiction. 1996; 91:1179-1186.
9. Hallstrom C, Lader M. Benzodiazepine withdrawal phenomenon. Int Pharmacopsychiatry. 1981;16:235-244.
10. Prabhat K, Murthy C, Murthy P. Mega Dose Lorazepam Dependence. Addiction. 2003; 98:1633.